Evaluation of circulating adipokines and abdominal obesity as predictors of significant myocardial ischemia using gated single-photon emission computed tomography

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Hung, Chi Sheng ^a   Wu, Yen Wen ^a,b,c   Huang, Jei Yie ^a   Hsu, Pei Ying ^a   Chen, Ming Fong ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CHEMERIN; FATTY ACID BINDING PROTEIN 4; TRIACYLGLYCEROL; ADIPOCYTOKINE; FABP4 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN;

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY MASS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; AREA UNDER THE CURVE; BLOOD; COMPLICATION; MYOCARDIAL ISCHEMIA; PATHOLOGY; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; RISK;

ADIPOKINES; ADIPONECTIN; AREA UNDER CURVE; BODY MASS INDEX; FATTY ACID-BINDING PROTEINS; HUMANS; MYOCARDIAL ISCHEMIA; OBESITY, ABDOMINAL; ODDS RATIO; RISK FACTORS; ROC CURVE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; WAIST CIRCUMFERENCE;

EID: 84901374435     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097710     Document Type: Article

References (46)

1. Hu FB, Willett WC, Li T, Stampfer MJ, Colditz GA, et al. (2004) Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med 351: 2694-2703. (Pubitemid 39665323)
2. Calle EE, Thun MJ, Petrelli JM, Rodrigues C, Heath CDW (1999) Body mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341: 1097-1105. (Pubitemid 29466221)
3. Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11: 85-97.
4. Tilg H, Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6: 772-783. (Pubitemid 44453463)
5. Gustafson B, Hammarstedt A, Andersson CX, Smith U (2007) Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 27: 2276-2283. (Pubitemid 350203940)
6. See R, Abdullah SM, McGuire DK, Khera A, Patel MJ, et al. (2007) The association of differing measures of overweight and obesity with prevalent atherosclerosis: the Dallas Heart Study. J Am Coll Cardiol 50: 752-759. (Pubitemid 47239312)
7. Lakka HM, Lakka TA, Tuomilehto J, Salonen JT (2002) Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J 23: 706-713. (Pubitemid 35230700)
8. Rajala MW, Scherer PE (2003) Minireview: The adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144: 3765-3773. (Pubitemid 37088727)
9. Jin J, Peng DQ, Yuan SG, Zhao SP, Ning XH, et al. (2010) Serum adipocyte fatty acid binding proteins and adiponectin in patients with coronary artery disease: the significance of A-FABP/adiponectin ratio. Clinic Chimica Acta 411: 1761-1765.
10. Bao Y, Lu Z, Zhou M, Li H, Wang Y, et al. (2011) Serum levels of adipocyte fatty acid-binding protein are associated with the severity of coronary artery disease in Chinese women. Plos One 6: e19115.
11. Hong J, Gu W, Zhang Y, Yan Q, Dai M, et al. (2011) Different association of circulating levels of adipocyte and epidermal fatty acid-binding proteins with metabolic syndrome and coronary atherosclerosis in Chinese adults. Atherosclerosis 217: 194-200
12. von Eynatten M, Breitling LP, Roos M, Baumann M, Rothenbacher D, et al. (2012) Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study. Arterioscler Thromb Vasc Biol 32: 2327-2335.
13. Ernst MC, Sinal CJ (2010) Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab 21: 660-667.
14. Yan Q, Zhang Y, Hong J, Gu W, Dai M, et al. (2012) The association of serum chemerin level with risk of coronary artery disease in Chinese adults. Endocrine 41:281-288.
15. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, et al. (2012) Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 60: e44-e164.
16. Shaw LJ, Iskandrian AE (2004) Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 11: 171-185. (Pubitemid 38949912)
17. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS (2003) Comparison of the short-term survival benefit associated with revascularization compared with medical therapy. Circulation 107: 2900-2907.
18. American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33 Suppl 1: S62-69.
19. Tan CE, Ma S, Wai D, Chew SK, Tai ES (2004) Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 27: 1182-1186. (Pubitemid 38579787)
20. Wang SY, Cheng MF, Hwang JJ, Hung CS, Wu YW (2011) Sex-specific normal limits of left ventricular ejection fraction and volumes estimated by gated myocardial perfusion imaging in adult patients in Taiwan: a comparison between two quantitative methods. Nucl Med Commun 32: 113-120.
21. Wu YW, Kao HL, Huang CL, Chen MF, Lin LY, et al. (2012) The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers. Eur J Nucl Med Mol Imaging 39: 399-407.
22. Wu YT, Chien CL, Wang SY, Yang WS, Wu YW (2013) Gender differences in myocardial perfusion defect in asymptomatic postmenopausal women and men with and without diabetes mellitus. J Womens Health (Larchmt) 22: 439-444.
23. Mahabadi AA, Massaro JM, Rosito GA, Levy D, Murabito JM, et al. (2009) Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J 30: 850-856.
24. Yoon MY, Sung JM, Song CS, Lee WY, Rhee EJ, et al. (2012) Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH. Clin Mol Hepatol 18: 279-286.
25. Xu A, Wang Y, Xu JY, Stejskal D, Tam S, et al. (2006) Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 52: 405-413.
26. Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS (2000) Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141: 3388-3396. (Pubitemid 32269028)
27. Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, et al. (2001) Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 7: 699-705. (Pubitemid 32588026)
28. Kvist H, Chowdhury B, Grangård U, Tylén U, Sjöström L (1988) Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am J Clin Nutr 48: 1351-61. (Pubitemid 19008565)
29. Kotani K, Tokunaga K, Fujioka S, Kobatake T, Keno Y, et al. (1994) Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes Relat Metab Disord 18: 207-212. (Pubitemid 24123455)
30. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, et al. (1996) Serum immunoreactive-leptin concentrations in normal weight and obese humans. N Engl J Med 334: 292-295. (Pubitemid 26033933)
31. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, et al. (2002) Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51: 2734-2741. (Pubitemid 34970926)
32. Takahashi M, Inomata S, Okimura Y, Iguchi G, Fukuoka H, et al. (2013) Decreased serum chemerin levels in male Japanese patients with type 2 diabetes: sex dimorphism. Endocr J 60: 37-44.
33. Karastergiou K, Smith SR, Greenberg AS, Fried SK (2012) Sex differences in human adipose tissues - the biology of pear shape. Biol Sex Differ 3: 13.
34. Nishikimi T, Mori Y, Ishimura K, Tadokoro K, Yagi H, et al. (2004) Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function. Am J Med 116: 517-523. (Pubitemid 38452642)
35. Bocek T, Morgenthaler NG, Staub D, Nusbaumer C, Christ A, et al. (2005) Use of pro-atrial natriuretic peptide in the detection of myocardial infarction. Eur J Clin Invest 35: 450-456. (Pubitemid 40992775)
36. Zaid G, Tanchilevitch A, Rivlin E, Gropper R, Rosenschein U, et al. (2007) Diagnostic accuracy of serum B-type natriuretic peptide for myocardial ischemia detection during exercise testing with Spect perfusion imaging. Int J Cardiol 117: 157-164. (Pubitemid 46454412)
37. Huang CL, Wu YW, Wu CC, Lin L, Wu YC, et al. (2013) Association between serum adipocyte fatty-acid binding protein concentrations, left ventricular function and myocardial perfusion abnormalities in patients with coronary artery disease. Cardiovasc Diabetol. 12: 105.
38. Kralisch S, Fasshauer M (2013) Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease? Diabetologia 56: 10-21.
39. Bozaoglu K, Segal D, Shields KA, Cummings N, Curran JE, et al. (2009) Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. J Clin Endocrinol Metab 94: 3085-3088.
40. Weigert J, Neumeier M, Wanninger J, Filarsky M, Bauer S, et al. (2010) Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf) 72: 342-348.
41. Xiaotao L, Xiaoxia Z, Yue X, Liye W (2012) Serum chemerin levels are associated with the presence and extent of coronary artery disease. Coron Artery Dis. 23: 412-416.
42. Yan Q, Zhang Y, Hong J, Gu W, Dai M, et al. (2012) The association of serum chemerin level with risk of coronary artery disease in Chinese adults. Endocrine 41: 281-288.
43. Dong B, Ji W, Zhang Y (2011) Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome. Intern Med 50: 1093-1097.
44. Lehrke M, Becker A, Greif M, Stark R, Laubender RP, et al. (2009) Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol 161: 339-344.
45. Hah YJ, Kim NK, Kim MK, Kim HS, Hur SH, et al. (2011) Relationship between chemerin levels and cardiometabolic parameters and degree of coronary stenosis in Korean patients with coronary artery disease. Diabetes Metab J 35: 248-254.
46. Chien CL, Wu YW, Yang WS, Yang PC, Su HM, et al. (2011) Myocardial perfusion image in asymptomatic postmenopausal women with physical inactivity and overweight. Obesity Facts 4: 372-378.